Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

NCT07246564 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis

Interventions

DRUG: Rozanolixizumab

Sponsor

UCB Biopharma SRL